⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9955330 | 0.96 | MEN1 (0.39) | — | |
| SCHEMBL559048 | 0.96 | MEN1 (0.39) | — | |
| SCHEMBL1154318 | 0.96 | MEN1 (0.39) | — | |
| SCHEMBL20432272 | 0.87 | — | — | |
| SCHEMBL12896587 | 0.86 | — | — | |
| SCHEMBL18970642 | 0.85 | — | — | |
| SCHEMBL9327882 | 0.85 | — | — | |
| SCHEMBL24936533 | 0.83 | KDM4E (0.36) | — | |
| SCHEMBL16328524 | 0.83 | MEN1 (0.31) | — | |
| SCHEMBL12143358 | 0.83 | MEN1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11564992-B2 | Nucleophilic catalysts for oxime linkage | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2023-01-31 | — | — | US | claimed |
| CN-109620963-B | Nucleophilic catalysts for oxime linkage | 武田药品工业株式会社 | 2022-10-28 | — | — | CN | claimed |
| EP-4023247-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | Takeda Pharmaceutical Company Limited (JP) | 2022-07-06 | — | — | EP | claimed |
| EP-4019049-A1 | METHODS FOR PREPARING THERAPEUTIC PROTEIN-POLYMER CONJUGATES | Takeda Pharmaceutical Company Limited (JP) | 2022-06-29 | — | — | EP | claimed |
| EP-3505186-B1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | TAKEDA PHARMACEUTICALS CO (JP) | 2022-01-12 | — | — | EP | claimed |
| US-20210163527-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2021-06-03 | — | — | US | claimed |
| US-20200230252-A1 | NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2020-07-23 | — | — | US | claimed |
| EP-3673921-A1 | MATERIALS AND METHODS FOR CONJUGATING A WATER SOLUBLE FATTY ACID DERIVATIVE TO A PROTEIN | Baxalta GmbH (CH) | 2020-07-01 | — | — | EP | claimed |
| EP-2654794-B1 | MATERIALS AND METHODS FOR CONJUGATING A WATER SOLUBLE FATTY ACID DERIVATIVE TO A PROTEIN | Baxalta GmbH (CH) | 2020-03-04 | — | — | EP | claimed |
| US-10576160-B2 | Nucleophilic catalysts for oxime linkage | BAXALTA INCORPORATED (US) | 2020-03-03 | — | — | US | claimed |
| US-20110027350-A1 | GLYCOPOLYSIALYLATION OF NON-BLOOD COAGULATION PROTEINS | LIPOXEN TECHNOLOGIES LIMITED (GB) | 2011-02-03 | — | — | US | claimed |
| US-20100009917-A1 | Modulating Enzymatic Processes by Addition of Diolcontaining Substances | NOVO NORDISK HEALTH CARE AG (CH) | 2010-01-14 | — | — | US | claimed |
| EP-2121952-A1 | MODULATING ENZYMATIC PROCESSES BY ADDITION OF DIOLCONTAINING SUBSTANCES | Novo Nordisk Health Care AG (CH) | 2009-11-25 | — | — | EP | claimed |
| US-20090264366-A1 | Transglutaminase Mediated Conjugation of Peptides | NOVO NORDISK HEALTHCARE AG (CH) | 2009-10-22 | — | — | US | claimed |
| EP-2033662-A1 | Transglutaminase mediated conjugation of peptides | Novo Nordisk Health Care AG (CH) | 2009-03-11 | — | — | EP | claimed |
| WO-2008101957-A1 | MODULATING ENZYMATIC PROCESSES BY ADDITION OF DIOLCONTAINING SUBSTANCES | NOVO NORDISK HEALTH CARE AG (DK) | 2008-08-28 | — | — | WO | claimed |
| JP-2007518747-A | — | — | 2007-07-12 | — | — | JP | claimed |
| US-20070105770-A1 | Transglutaminase mediated conjugation of peptides | NOVO NORDISK A/S (DK) | 2007-05-10 | — | — | US | claimed |
| EP-1708755-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2006-10-11 | — | — | EP | claimed |
| WO-2005070468-A2 | TRANSGLUTAMINASE MEDIATED CONJUGATION OF PEPTIDES | NOVO NORDISK A/S (DK) | 2005-08-04 | — | — | WO | claimed |